1. Ahmedat AS, Warnken M, Stöber M, Juergens UR, Racké K (2010) Characterization of endothelinergic mechanisms in human lung fibroblasts Naunyn-Schmiedeberg’s. Arch Pharmacol 381(Suppl-1):57
2. Baker JG (2005) The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144:317–322
3. Barnes PJ (2004) The role of anticholinergics in chronic obstructive pulmonary disease. Am J Med 117(Suppl 12A):24S–32S
4. Bos JL (2006) Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31:680–686
5. Bouvier M, Collins S, O’Dowd BF, Campbell PT, de Blasi A, Kobilka BK, MacGregor C, Irons GP, Caron MG, Lefkowitz RJ (1989) Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem 264:16786–16792